74552 Federal Register / Vol. 71, No. 238 / Tuesday, December 12, 2006 / Notices 

develop, evaluate, or commercialize 

phospho-specific PDK–1 antibody and 

insulin signaling. Please contact 

Michael J. Quon, Chief, Diabetes Unit, 

NCCAM, NIH at quonm@nih.gov for 

more information. 

Dated: December 6, 2006. 

Steven M. Ferguson, 

Director, Division of Technology Development 

and Transfer, Office of Technology Transfer, 

National Institutes of Health. 

[FR Doc. E6–21037 Filed 12–11–06; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Library of Medicine; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The portions of the meeting devoted 

to the review and evaluation of journals 

for potential indexing by the National 

Library of Medicine will be closed to the 

public in accordance with the 

provisions set forth in section 

552b(c)(9)(B), Title 5 U.S.C., as 

amended. Premature disclosure of the 

titles of the journals as potential titles to 

be indexed by the National Library of 

Medicine, the discussions, and the 

presence of individuals associated with 

these publications could significantly 

frustrate the review and evaluation of 

individual journals. 

Name of Committee: Literature Selection 

Technical Review Committee. 

Date: February 22–23, 2007. 

Open: February 22, 2007, 9 a.m. to 11 a.m. 

Agenda: Administrative reports and 

program discussions. 

Place: National Library of Medicine, 

Building 38, Board Room, 2nd Floor, 8600 

Rockville Pike, Bethesda, MD 20894. 

Closed: February 22, 2007, 11 a.m. to 5 

p.m. 

Agenda: To review and evaluate journals 

as potential titles to be indexed by the 

National Library of Medicine. 

Place: National Library of Medicine, 

Building 38, Board Room, 2nd Floor, 8600 

Rockville Pike, Bethesda, MD 20894. 

Closed: February 23, 2007, 8:30 a.m. to 2 

p.m. 

Agenda: To review and evaluate journals 

as potential titles to be indexed by the 

National Library of Medicine. 

Place: National Library of Medicine, 

Building 38, Board Room, 2nd Floor, 8600 

Rockville Pike, Bethesda, MD 20894. 

Contact Person: Sheldon Kotzin, MLS, 

Associate Director, Division of Library 

Operations, National Library of Medicine, 

8600 Rockville Pike, Bldg 38/Room 2W06, 

Bethesda, MD 20894, 301–496–6921. 

Sheldon_Kotzin@nlm.nih.gov. 

Any interested person may file written 

comments with the Committee by forwarding 

the statement to the Contact Person listed on 

this Notice. The statement should include the 

name, address, telephone number and, when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

into the building by non-government 

employees. Persons without a government 

I.D. will need to show a photo I.D. and sign 

in at the security desk upon entering the 

building. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.879, Medical Library 

Assistance, National Institutes of Health, 

HHS) 

Dated: December 4, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy, NIH. 

[FR Doc. 06–9631 Filed 12–11–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[USCG 2006–25522] 

Exercise of Authority To Require Pilots 

To Submit Results of Annual Chemical 

Test for Dangerous Drugs and 

Extension of Deadline for Pilots To 

Submit Most Recent Annual Physical 

Examination 

ACTION: Notice. 

SUMMARY: By this notice, the Coast 

Guard is exercising authority currently 

set forth in Coast Guard regulations to 

require all first class pilots on vessels 

greater than 1600 gross registered tons 

(GRT), and other individuals who 

‘‘serve as’’ pilots on certain types of 

vessels greater than 1600 GRT, to 

provide the passing results of their 

annual chemical test for dangerous 

drugs to the Coast Guard, subject to 

certain exceptions. In addition, the 

Coast Guard is extending the deadline 

for pilots to submit the most recent copy 

of their annual physical examination. 

FOR FURTHER INFORMATION CONTACT: Mr. 

Stewart A. Walker, National Maritime 

Center. Phone: 202–493–1022, e-mail: 

Stewart.A.Walker@uscg.mil 

DATES: Unless excepted under 46 CFR 

16.220(c), each pilot must do the 

following: Submit the passing results of 

his or her most recent annual chemical 

test for dangerous drugs to the Coast 

Guard on or before April 11, 2007; 

submit the passing results of his or her 

annual chemical test for dangerous 

drugs to the Coast Guard no later than 

30 calendar days after receiving the 

results of the test; and undergo a 

chemical test for dangerous drugs 

annually within 30 calendar days of the 

anniversary date of the individual’s 

most recent chemical test for dangerous 

drugs. 

In addition, the Coast Guard is 

extending the deadline for pilots to 

submit a copy of their most recent 

physical examinations until April 11, 

2007. This information was initially 

requested to be submitted to the Coast 

Guard no later than December 27, 2006 

in a Federal Register notice published 

on September 28, 2006 at 71 FR 56999. 

SUPPLEMENTARY INFORMATION: On 

September 28, 2006, the Coast Guard 

provided notice that it is exercising its 

authority to require first class pilots on 

vessels greater than 1600 GRT, and 

those individuals who ‘‘serve as’’ pilots 

in accordance with 46 CFR 15.812(b)(3) 

& (c) on vessels greater than 1600 GRT, 

to submit copies of their annual 

physical examinations to the Coast 

Guard. 71 Fed. Reg. 56999. Copies of 

that notice, as well as this notice are 

available electronically by searching for 

docket number USCG–2006–25522 at 

http://dms.dot.gov. The purpose of the 

physical examination notice was to 

implement the recommendation made 

by the National Transportation Safety 

Board (NTSB), in their report on the 

2003 allision of the Staten Island Ferry 

ANDREW J. BARBERI, that the Coast 

Guard require submission of annual 

pilot physicals. This notice is a 

continuation of the Coast Guard’s efforts 

to fully implement the NTSB’s 

recommendation. 

Coast Guard regulations require that, 

unless excepted under 46 CFR 

16.220(c), each pilot who is required to 

complete an annual physical 

examination must also pass a chemical 

test for dangerous drugs, and that he or 

she must submit the passing (i.e. 

negative) results of the chemical test to 

the Coast Guard when applying for 

license renewal, or when requested by 

the Coast Guard. 46 CFR 16.220(b). This 

includes first class pilots on vessels 

greater than 1600 GRT, and those 

individuals who ‘‘serve as’’ pilots in 

accordance with 46 CFR 15.812(b)(3) & 


jlentini on PROD1PC65 with NOTICES